Clinical trial
Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With…
NCT00014508 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00014508 |
|---|---|
| Title | Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma |
| Official title | A Phase II Trial Of Autologous Stem Cell Transplant Followed By Mini-Allogeneic Stem Cell Transplant In Lieu Of Standard Allogeneic Bone Marrow Transplantation For Treatment Of Multiple Myeloma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma and Plasma Cell Neoplasm |
| Intervention type | Biological, Drug, Procedure |
| Interventions | sargramostim, cyclophosphamide, cyclosporine, fludarabine phosphate, melphalan, peripheral blood stem cell transplantation |
| Start date | Nov 19, 2001 |
| Primary completion | Feb 1, 2007 |
| Completion | May 27, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: